As cited by the business intelligence report titled ‘Global Clinical Microbiology Market Size study, by Product (Instruments and Reagents), by Application (Pharmaceuticals Applications, Food Testing Applications, Clinical Applications, Energy Applications, Chemical & Material Manufacturing Applications and Environmental Applications), by Disease (Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections, Periodontal Diseases and Other Indications), by End User (Hospitals & Diagnostics Centers, Custom Lab Service Providers and Academic & Research Institutes) and Regional Forecasts 2020-2027’, available with Market Study Report, worldwide clinical microbiology market was valued USD 3.7 billion in 2019 and is estimated to grow at 6.5% CAGR during 2020-2027, subsequently accruing USD 6.1 billion by the end of the study period.
 

Rising prevalence of infectious diseases, outbreaks of epidemics, and ongoing technological advancements in disease diagnostics are bolstering global clinical microbiology market growth. Increasing number of public-private investments in healthcare sector and rising research & development activities are further propelling the industry expansion.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3029654/
 

For the record, clinical microbiology is a medical practice which is primarily aimed at studying and identifying infection-causing microbes in the human body. The method comprises of a vast range of testing methodologies which mainly focus on the treatment of infectious diseases caused by viruses, bacteria, parasites, fungi, and other microorganisms.
 

Speaking of the latest developments, the Covid-19 pandemic has accelerated global clinical microbiology industry expansion owing to increased focus on R&D of vaccines. On the contrary, lack of reimbursement policies pertaining to microbiology testing procedures will continue to restrict the market growth during the stipulated timeframe.
 

Based on product type, worldwide clinical microbiology market is split into reagents and instruments. With regards to disease type, the business sphere comprises periodontal diseases, urinary tract infections, sexually transmitted diseases gastrointestinal diseases, bloodstream infections, and respiratory diseases among others.
 

Moving on, the application scope of the industry is bifurcated into environmental applications, chemical & material manufacturing, energy applications, clinical applications, food testing, and pharmaceutical applications.
 

Regionally, North America captures a significant portion of global clinical microbiology market share and will likely showcase strong growth trends in the coming years. This can be accredited to presence of well-established distribution channels for product manufacturers and suppliers, along with increasing penetration of clinical microbiology technologies in the region.
 

On the other hand, Asia-Pacific marketplace is anticipated to register the grow exponentially during the forecast period.
 

Top-tier companies influencing the global clinical microbiology industry trends are Abbott Laboratories, Hologic, Inc., 3M Co., Agilent Technologies, Inc., BioMérieux S.A., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Danaher Corp., Bruker Corp, and Merck Group.